<DOC>
	<DOC>NCT02447900</DOC>
	<brief_summary>Proof of concept study evaluating safety and performance of a gel marker (BioXmark) used for image guidance in deep inspiration breathhold radiotherapy (DIBH IGRT) in patients with locally advanced non-small cell lung cancer (NSCLC)</brief_summary>
	<brief_title>Marker Guided Breathhold Radiotherapy in NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Inclusion criteria Age &gt; 18 years old Histologically confirmed nonsmall cell lung cancer (NSCLC) Stage T14N13M0 Performance status ≤ 2 Inoperable FEV1 ≥ 1 l Ability to hold deep inspiration breathhold for &gt; 15 seconds Accepting treatment at Rigshospitalet Eligible for concomitant chemoradiotherapy If a woman is of childbearing potential, a negative pregnancy test must be documented Ability to understand the given information Signed written consent for inclusion into the study Exclusion criteria Prior thoracic radiotherapy Allergy to Iodine or iodine based contrast In the opinion of the investigator, the patient will not be able to follow the study procedures or is considered not eligible for other reasons</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>